|
4-{4-[(2E)-3-phenylprop-2-en-1-yl]piperazin-1-yl}-5H-pyrimido[5,4-b]indole |
|
Salmonella |
Biofilm |
Preclinical (in vitro) |
Robijns SC, et al. 2012. FEMS Immunol Med Microbiol |
|
7,8-dimethoxy-4-{4-[(2E)-3-phenylprop-2-en-1-yl]piperazin-1-yl}-5H-pyrimido[5,4-b]indole |
Depiction based on curated SMILES
N
H
N
H
3
C
N
N
N
CH
3
O
O
|
Salmonella |
Biofilm |
Preclinical (in vitro) |
Robijns SC, et al. 2012. FEMS Immunol Med Microbiol |
|
7-methoxy-4-{4-[(2E)-3-phenylprop-2-en-1-yl]piperazin-1-yl}-5H-pyrimido[5,4-b]indole |
Depiction based on curated SMILES
N
N
CH
3
N
N
HN
O
|
Salmonella |
Biofilm |
Preclinical (in vitro) |
Robijns SC, et al. 2012. FEMS Immunol Med Microbiol |
|
7-methyl-4-{4-[(2E)-3-phenylprop-2-en-1-yl]piperazin-1-yl}-5H-pyrimido[5,4-b]indole |
Depiction based on curated SMILES
N
N
CH
3
N
N
NH
|
Salmonella |
Biofilm |
Preclinical (in vitro) |
Robijns SC, et al. 2012. FEMS Immunol Med Microbiol |
|
8-fluoro-4-{4-[(2E)-3-phenylprop-2-en-1-yl]piperazin-1-yl}-5H-pyrimido[5,4-b]indole |
Depiction based on curated SMILES
N
N
F
N
N
N
H
|
Salmonella |
Biofilm |
Preclinical (in vitro) |
Robijns SC, et al. 2012. FEMS Immunol Med Microbiol |
|
9-methoxy-4-{4-[(2E)-3-phenylprop-2-en-1-yl]piperazin-1-yl}-5H-pyrimido[5,4-b]indole |
Depiction based on curated SMILES
HN
N
CH
3
N
N
N
O
|
Salmonella |
Biofilm |
Preclinical (in vitro) |
Robijns SC, et al. 2012. FEMS Immunol Med Microbiol |
|
N-methyl-3-(1-(4-(piperazin-1-yl)phenyl)-5-(4'-(trifluoromethyl)-[1,1'-biphenyl]-4-yl)-1H-pyrazol-3-yl)propanamide |
Depiction based on curated SMILES
F
F
F
N
H
O
N
N
CH
3
N
N
H
|
Acinetobacter Salmonella |
Biofilm Biofilm |
Preclinical (in vitro) Preclinical (in vitro) |
Moshiri J, et al. 2018. Front Microbiol
|
|
| | |
| | |
| | |
| | |
| | |
| | |
| | |